DSDiana A. Sarkisyan

Diana A. Sarkisyan

*This is an algorithmically generated author record based on publicly available information.

Diana A. Sarkisyan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phenotypic and molecular genetic predictors of Wolff-Parkinson-White syndrome

    by Yu. A. Tolstokorova, S. Yu. Nikulina, A. A. Chernova, D. A. Sarkisyan

    Aim. To study the phenotypic and molecular genetic characteristics of patients with Wolff-Parkinson-White (WPW) syndrome. Material and methods. The study group consisted of 200 patients with WPW syndrome, including 97 men (n=48,5%) and 103 women (n=51,5%). All patients underwent clinical and paraclinical examinations, including electrocardiography (ECG), Holter monitoring, echocardiography, somatometry according to the standard V. V. Bunak method, and molecular genetic testing. DNA was extracted using the phenol-chloroform method, and genotyping was performed using the polymerase chain reaction. Results. Multivariate regression analysis revealed significant associations between some factors and WPW syndrome. The strongest predictor was a delta wave on the ECG (odds ratio (OR) =21,3; pConclusion. Heredity is a key factor in the development of WPW syndrome, as confirmed by data from numerous studies. Phenotypic characteristics, in addition to genetic markers, can serve as a valuable tool for risk stratification and the development of preventive strategies aimed at preventing the manifestation of WPW syndrome.

  • Open Access

    Investigation of the effect of the rs692243 polymorphism of the PRKAG3 gene on the development of WPW syndrome

    by Yu. A. Tolstokorova, S. Yu. Nikulina, A. A. Chernova, D. A. Sarkisyan, D. A. Brusentsov, A. A. Lobastova

    Objective: to identify the association of polymorphic allelic variant rs692243 of the PRKAG3 gene with the development of WPW syndrome. Materials and methods: the study included 200 patients with WPW syndrome. To conduct the case–control study, a control group of 200 volunteers of comparable age and gender was selected, whose observation and health status were assessed during the WHO international projects «MONICA» and «HAPPIE». Comprehensive examination of patients included clinical, laboratory and instrumental studies. Diagnostic instrumental studies: electrocardiography (ECG), Holter ECG monitoring (XM-ECG), echocardiography (EchoCG), All patients of the main and control groups underwent a molecular genetic study. The phenol-chloroform DNA extraction technique was used in our patients. PCR-RDF analysis (polymerase chain reaction-restriction fragment length polymorphism) is a standard genotyping method for the study of the PRKAG3 gene. Statistical data processing was carried out using the Excel application software package, Statistica for Windows 10.0, IBM SPSS 20. The statistical significance in the analysis of the frequencies of alleles and genotypes of the PRKAG3 gene between the main and control groups was verified using the criterion χ2. The indicator of the relative risk of WPW syndrome for certain alleles and genotypes was identified as the odds ratio (OR). To carry out a one-factor logistic regression analysis, a step-by-step inclusion of indicators was carried out, which showed significant differences at the level of 0.1. Results: significant differences in the frequencies of genotypes and alleles for rs692243 of the PRKAG3 gene were found when comparing patients with WPW syndrome with those in the control group. The revealed frequency of the CC rs692243 genotype of the PRKAG3 gene in the main group of subjects was 8% (16 people), in the group of healthy volunteers -2% (4 people) (p Conclusion: the revealed associations of the single nucleotide variant rs629243 of the PRKAG3 gene with the development of WPW syndrome prove the risky influence of the CC genotype and the C allele on the development of this pathology.

  • Open Access

    Association of rs1061657 single nucleotide polymorphism of the TBX3 gene with Wolff–Parkinson–White syndrome

    by Julia A. Tolstokorova, Svetlana Yu. Nikulina, Anna A. Chernova, Diana A. Sarkisyan, Anna A. Dyakonova, Anastasia A. Lobastova

    BACKGROUND: Wolff–Parkinson–White syndrome is one of the most well-known heart rhythm disorders characterized by pre-excitation of the ventricles. This phenomenon occurs because the electrical impulse passes through an additional conduction pathway between the atria and the ventricles. The syndrome is most commonly associated with the likelihood of supraventricular tachycardia. Numerous studies indicate the presence of a genetic component in the pathogenesis of the Wolff–Parkinson–White syndrome, which confirms its complex nature. AIM: The study aimed to investigate the association of the rs1061657 single nucleotide polymorphism of the TBX3 gene with the Wolff–Parkinson–White syndrome. METHODS: Patients diagnosed with the Wolff–Parkinson–White syndrome, manifesting in various clinical forms, including the Wolff–Parkinson–White phenomenon, were recruited over five years for a study based at the Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University. A total of 200 patients with the Wolff–Parkinson–White syndrome, encompassing those with the Wolff–Parkinson–White phenomenon, were examined for this paper. This group included 97 males (48.5%) and 103 females (51.5%) with a mean age of 31.9 ± 15.8 years and 38.8 ± 20.0 years, respectively. All patients underwent standard clinical, laboratory, and instrumental examinations (electrocardiography, Holter monitoring, echocardiography), as well as molecular genetic testing. All patients were divided into the following groups by the clinical variants of the disease: 90 patients (45%) with the manifest Wolff–Parkinson–White syndrome; 60 patients (30%) with the intermittent Wolff–Parkinson–White syndrome; 46 patients (23%) with the latent Wolff–Parkinson–White syndrome; and 4 patients (2%) with the Wolff–Parkinson–White phenomenon. Excel, Statistica for Windows 10.0 (StatSoft, USA), and SPSS 20 (IBM, USA) were used for the statistical data processing. RESULTS: A statistically significant predominance of the homozygous GG genotype was observed in the distribution of genotypes of the rs1061657 polymorphism of the TBX3 gene in patients with the Wolff–Parkinson–White syndrome compared with the control group (12.5% vs 5.5%, respectively). Furthermore, a statistically significant predominance of the G allele carriers was observed in patients with the Wolff–Parkinson–White syndrome (31.75%) compared with the control group (24.5%). The estimated risk based on odds ratio for the Wolff–Parkinson–White syndrome in the GG genotype of the TBX3 gene was 1.323-fold higher (95% confidence interval: 0.866–2.023; p = 0.04) compared with the GA and AA genotypes. In the G allele carriers, the odds ratio for the Wolff–Parkinson–White syndrome was 1.434-fold higher (95% confidence interval: 1.051–4.127; p = 0.028) compared with the A allele. CONCLUSION: The study results confirmed that the rs1061657 polymorphism of the TBX3 gene contributes to the development of the Wolff–Parkinson–White syndrome.